US Patent 12023368 Immunoconjugates
Patent 12023368 was granted and assigned to Hoffmann-La Roche Limited on July, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jul, 2024
Golden AI
Edits made to:
Infobox (+52 properties)
Article (+501 characters)
US Patent 12023368 Immunoconjugates
Article
Patent abstract
The present invention generally relates to immunoconjugates, particularly immunoconjugates comprising a mutant interleukin-2 polypeptide and an antibody that binds to PD-1. In addition, the invention relates to polynucleotide molecules encoding the immunoconjugates, and vectors and host cells comprising such polynucleotide molecules. The invention further relates to methods for producing the mutant immunoconjugates, pharmaceutical compositions comprising the same, and uses thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christian Klein0
Inja Waldhauer0
Laura Codarri Deak0
Laura Lauener0
Pablo Umana0
Stefan Seeber0
Valeria G. Nicolini0
Date of Patent
July 2, 2024
0Patent Application Number
178100410
Date Filed
June 30, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12023368 Immunoconjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.